ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Electra Therapeutics, Inc.
$8.61−0.14 (-1.60%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Electra Therapeutics, Inc. income statement
Ratios
Latest available
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY
- –
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –